Effects of different anticoagulants on coagulation time and plasma protein adsorption during hemodialysis

Read full text Summarise with VIRAT
Authors: Li Yuan-yuan, Zhang Ming, Liu Qian, Sun Shao-ting, Liu Yi-kun, Yan Shu-he, Du Shu-tong
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ObjectiveTo evaluate the effects of different anticoagulants (sodium citrate, low‑molecular‑weight heparin[LMWH], and unfractionated heparin [UFH]) on coagulation times and plasma protein adsorption characteristics during hemodialysis, and to investigate, based on clinical data, the impact of anticoagulant use on plasma protein loss.MethodsIn vitro experiments were performed by adding different concentrations of anticoagulants[sodium citrate, low‑molecular‑weight heparin (LMWH) and unfractionated heparin (UFH)] (100, 500, 1000, 5000, 10 000, 20 000 IU/L) to plasma samples from healthy volunteers. Coagulation times, including prothrombin time (PT), activated partial thromboplastin time (APTT) and thrombin time (TT), were measured using a COAG‑AUTO 5000 automated coagulation analyzer. SDS‑PAGE and surface plasmon resonance (SPR) techniques were used to analyze the effects of the anticoagulants on adsorption of albumin and fibrinogen. The clinical component retrospectively analyzed from January 2023 to December 2024 120 hemodialysis patients to assess relationships between anticoagulant choice and changes in total plasma protein and albumin levels.ResultsIn vitro, LMWH significantly prolonged APTT at relatively low concentration (1000 IU/L) (prolongation≥20%) and showed the strongest adsorption to albumin and fibrinogen at 5000 IU/L (adsorption increases of approximately 45% and 38%, respectively). Clinical data indicated that the LMWH group had smaller albumin loss after dialysis [albumin decreased from (38.2±3.1) g/L to (33.6±2.8) g/L, a decline of (12±3)%], and 80% of patients had no dialyzer clotting (grade 0). The sodium citrate group [albumin from (37.5±3.0) g/L to (30.3±2.9) g/L, decline (19±5)%] and the UFH group [albumin from (37.8±3.5) g/L to (31.7±3.2) g/L, decline (16±4)%] experienced greater albumin loss (P

Fields of Study & Subjects

Dialysis and Renal Disease Management Blood Coagulation and Thrombosis Mechanisms Blood properties and coagulation

Publication details

Journal / source
DOAJ (DOAJ: Directory of Open Access Journals)
Publication date
1 March 2026
Language
ZH